SELLAS Life Sciences Group, Inc. - Common Stock (SLS)
1.2700
-0.0100 (-0.78%)
Sellas Life Sciences Group Inc is a biotechnology company focused on the development of innovative immunotherapies for the treatment of cancer
The company is dedicated to advancing its therapeutic candidates through clinical trials, aiming to address unmet medical needs in oncology. By leveraging proprietary technology and scientific expertise, Sellas seeks to provide patients with effective treatment options that harness the body’s immune system to target and combat cancerous cells. Their pipeline includes various late-stage candidates designed to offer new hope for better outcomes in cancer care.
![](https://www.chartmill.com/images/uploads/CM_Aftermarket_Movers_Small_free_e077945a19.webp)
After the conclusion of the US market's regular session on Thursday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Via Chartmill · January 30, 2025
![](https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp)
Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · January 27, 2025
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
SLS stock results show that SELLAS Life Sciences Gr beat analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 13, 2024
![](https://cdn.benzinga.com/files/images/story/2024/01/04/annoy-2926087.jpg?width=1200&height=800&fit=crop)
Sellas Life Sciences Group Inc (NASDAQSLS) shares are trading lower by 35.7% to $0.58 Thursday afternoon.
Via Benzinga · January 4, 2024
![](https://cdn.benzinga.com/files/images/story/2024/06/17/movers.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · June 17, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
SLS stock results show that SELLAS Life Sciences Gr missed analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 14, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
SLS stock results show that SELLAS Life Sciences Gr missed analyst estimates for earnings per share the fourth quarter of 2023.
Via InvestorPlace · March 28, 2024
![](https://cdn.benzinga.com/files/images/story/2024/03/15/image30_0.jpeg?width=1200&height=800&fit=crop)
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling over 200 points on Friday. The Dow traded down 0.55% to 38,692.43 while the NASDAQ fell 0.90% to 15,982.65. The S&P 500 also fell, dropping, 0.64% to 5,117.35.
Via Benzinga · March 15, 2024
![](https://cdn.benzinga.com/files/images/story/2024/03/15/jabil_-_logo_0.jpg?width=1200&height=800&fit=crop)
Shares of Jabil Inc. (NYSEJBL) fell sharply during Friday’s session after the company reported financial second-quarter results and issued FY25 guidance below estimates.
Via Benzinga · March 15, 2024
![](https://cdn.benzinga.com/files/images/story/2024/03/15/image23_0.jpeg?width=1200&height=800&fit=crop)
U.S. stocks traded lower midway through trading, with the Dow Jones index falling over 100 points on Friday. The Dow traded down 0.37% to 38,761.74 while the NASDAQ fell 0.95% to 15,974.83. The S&P 500 also fell, dropping, 0.62% to 5,118.35.
Via Benzinga · March 15, 2024
![](https://cdn.benzinga.com/files/images/story/2024/03/15/image33.jpeg?width=1200&height=800&fit=crop)
U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 100 points on Friday. Following the market opening Friday, the Dow traded down 0.28% to 38,797.24 while the NASDAQ fell 0.67% to 16,020.07. The S&P 500 also fell, dropping, 0.58% to 5,120.59.
Via Benzinga · March 15, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · March 15, 2024
![](https://cdn.benzinga.com/files/images/story/2024/mining_0.jpeg?width=1200&height=800&fit=crop)
China-based Zijin Mining is investing $97 million in Solaris Resources. Proceeds will go toward an Ecuador-based project.
Via Benzinga · January 12, 2024
![](https://cdn.benzinga.com/files/images/story/2024/01/04/crude_oil_6-_logo.jpg?width=1200&height=800&fit=crop)
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index gaining over 100 points on Thursday. The Dow traded up 0.33% to 37,554.56 while the NASDAQ fell 0.10% to 14,578.04. The S&P 500 also rose, gaining, 0.09% to 4,708.93.
Via Benzinga · January 4, 2024
![](https://cdn.benzinga.com/files/images/story/2024/01/04/image39.jpeg?width=1200&height=800&fit=crop)
Shares of Mobileye Global Inc. (NASDAQMBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.<
Via Benzinga · January 4, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · January 4, 2024
![](https://cdn.benzinga.com/files/images/story/2024/01/04/image33.jpeg?width=1200&height=800&fit=crop)
U.S. stocks traded mostly higher midway through trading, with the Dow Jones index gaining around 200 points on Thursday. The Dow traded up 0.55% to 37,635.05 while the NASDAQ rose 0.05% to 14,599.10. The S&P 500 also rose, gaining, 0.28% to 4,718.19.
Via Benzinga · January 4, 2024
![](https://cdn.benzinga.com/files/images/story/2024/01/04/image19.jpg?width=1200&height=800&fit=crop)
U.S. stocks traded mixed this morning, with the Dow Jones index gaining around 50 points on Thursday. Following the market opening Thursday, the Dow traded up 0.15% to 37,487.49 while the NASDAQ fell 0.27% to 14,553.12. The S&P 500 also fell, dropping, 0.01% to 4,704.42.
Via Benzinga · January 4, 2024
![](https://investorplace.com/wp-content/uploads/2020/09/pton1600.jpg)
Peloton stock is heading higher on Thursday as investors in PTON react to the company signing a new partnership with TikTok.
Via InvestorPlace · January 4, 2024
![](https://investorplace.com/wp-content/uploads/2021/08/doctor_medicine_dna_1600.jpg)
Evotec stock is falling on Thursday with heavy trading of EVO shares following the resignation of the company's CEO, Dr. Werner Lanthaler.
Via InvestorPlace · January 4, 2024
![](https://investorplace.com/wp-content/uploads/2022/10/droplet-test-tube-biotech-1600-3.jpg)
Sellas Life Sciences stock is sliding lower on Thursday after the company announced a proposed public offering for shares of SLS.
Via InvestorPlace · January 4, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · January 4, 2024